2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Playback speed
10 seconds
ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degrader, in mCRPC - Initial Results of a Phase 1/2 Study"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Daniel Petrylak
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Daniel Petrylak
107 views
June 6, 2024
Comments 0
Login to view comments.
Click here to Login
GU